Assessment and treatment of childhood epilepsy in Haiti

Gabriel Crevier-Sorbo1, Tristan Brunette-Clément2, Edgar Medawar1

  • 1Faculty of Medicine McGill University Montreal QC Canada.

Epilepsia Open
|June 12, 2020
PubMed

Insights

Pediatric epilepsy treatment in Haiti showed improved seizure control for many children. Key factors for poor outcomes included abnormal neurological exams and developmental delays, informing resource allocation in low-income countries.

Area of Science:

  • Pediatric Neurology
  • Global Health
  • Epileptology

Background:

  • Pediatric epilepsy disproportionately affects low- and middle-income countries (LMICs).
  • Limited data exists on the effectiveness of epilepsy treatment programs in LMICs.
  • The Clinique D'Épilepsie de Port-au-Prince (CLIDEP) is Haiti's sole pediatric epilepsy referral center.

Purpose of the Study:

  • To evaluate the outcomes of children with epilepsy treated at CLIDEP in Haiti.
  • To identify factors associated with seizure control and diagnosis in pediatric epilepsy patients in a LMIC setting.

Main Methods:

  • A 10-year retrospective review of 812 children assessed and treated at CLIDEP.
  • Primary outcome: seizure control; Secondary outcome: accurate epilepsy diagnosis.
  • Principle component regression (PCR) analysis to identify outcome-associated variables.

Main Results:

  • Most children (82%) had electroencephalography; few (7%) had cranial imaging.
  • Despite high loss to follow-up (24%), 51% of returning children had less frequent seizures with 79% medication compliance.
  • PCR identified phenotypes associated with poor seizure control (neurological abnormalities, comorbidities, developmental delay) and epilepsy diagnosis (febrile seizures, higher seizure frequency).

Conclusions:

  • The study outlines the landscape of childhood epilepsy diagnosis, treatment, and outcomes in Haiti.
  • Findings support the effectiveness of epilepsy management programs in LMICs.
  • Results can guide resource allocation and improve referral structures for pediatric epilepsy in resource-limited settings.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.0K
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.2K
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
555